Shares of Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.75 and traded as low as $1.91. Aemetis shares last traded at $1.91, with a volume of 543,144 shares traded.
Wall Street Analyst Weigh In
A number of research analysts have commented on AMTX shares. HC Wainwright reaffirmed a "buy" rating and issued a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd. StockNews.com raised Aemetis to a "sell" rating in a research report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Aemetis has an average rating of "Hold" and a consensus price target of $14.56.
Get Our Latest Stock Report on AMTX
Aemetis Stock Performance
The stock has a market capitalization of $85.43 million, a price-to-earnings ratio of -0.74 and a beta of 1.44. The company has a 50-day moving average of $2.39 and a 200-day moving average of $2.74.
Institutional Investors Weigh In On Aemetis
Institutional investors and hedge funds have recently modified their holdings of the stock. ProShare Advisors LLC bought a new stake in shares of Aemetis in the 4th quarter valued at approximately $27,000. Tower Research Capital LLC TRC raised its stake in shares of Aemetis by 128.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company's stock worth $28,000 after buying an additional 5,859 shares in the last quarter. Voya Investment Management LLC acquired a new stake in Aemetis during the fourth quarter valued at approximately $28,000. Clear Harbor Asset Management LLC bought a new stake in shares of Aemetis during the 4th quarter worth $44,000. Finally, Intech Investment Management LLC purchased a new position in Aemetis in the 4th quarter worth about $46,000. Hedge funds and other institutional investors own 27.02% of the company's stock.
About Aemetis
(
Get Free Report)
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
See Also
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
